Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluarix 2006/2007 Immunogenicity Study
NCT00345904Phase 3Completed
- Sponsor
- GSK
- Start
- Jul 2006
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Fluarix in influenza, sponsored by GSK. Started Jul 2006; status: completed.
02
Drugs
Fluarix
03
Conditions
influenza
Beyond the preview
Go deeper on NCT00345904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00345904.